Clinical Trial Update: A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma. [Phase 4]

View source ↗

Summary

Phase IV clinical trial update evaluating ipilimumab in patients with advanced malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Oslo University Hospital | Conditions: Malignant Melanoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING